Skip to main content
. 2023 Apr 23;5(8):100764. doi: 10.1016/j.jhepr.2023.100764

Table 2.

Clinical characteristics of individuals investigated in generation IV.

MTTP genotype p.I564T Sex (male/female) Liver disease diagnosis (method) Age at testing (years) Type 2 diabetes BMI Hypertension Liver biochemistry and lipid blood analyses at diagnosis
IT M NASH (USS) 32 x 20 X ALT = 53, AP = 68, Chol = 7, TG = 3.14, VitD <15, TE = 7.4 kPa, CAP = 352
IT M FL (USS) 37 x 18 X Normal LFTs (ALT = 14), normal lipids; HbA1c = 9.5
IT M FL (USS) 40 x 28 X ALT = 74, Chol = 6, TG = 2.12, TE = 3.6 kPa, CAP = 373
IT F Healthy (USS) 29 x 20 X Normal LFTs (ALT = 13), normal lipids; ApoB = 0.95, TE = 3.5 kPa, CAP = 122
IT M Healthy (TE) 32 x 27 X TG = 2.57, Chol = 3.7, ApoB = 1.04, TE = 5.3 kPa
IT M Healthy (USS) 31 x 18 X Normal LFTs (ALT = 19), normal lipids
IT F Healthy (USS) 37 x 19 X Normal LFTs (ALT = 10), Chol = 4.2, TG = 1.77, ApoB = 0.96, TE = 4.2 kPa, CAP = 291
IT F Healthy (USS) 39 x 21 x Normal LFTs (ALT = 23), normal lipids
IT F Healthy (USS) 41 x 20 x Normal LFTs (ALT = 27), Chol = 4.6, TG = 2.15, ApoB = 1.02, TE = 3.1 kPa, CAP = 231
IT M Healthy (USS) 44 x <30 x Normal LFTs (ALT = 27), Chol = 3.5, TG = 2.4; TE = 5.5 kPa, CAP = 281
IT M Healthy (USS) 49 x <30 x Normal LFTs (ALT = 14), Chol = 4.88, TG = 0.98, ApoB = 1.09, TE = 5.1 kPa, CAP = 245
IT F FL (USS)
Healthy (USS)
35
38
x 21 x Normal LFTs (ALT = 12), Chol = 6, TG=1.5, ApoB = 1.31, TE = 4.2 kPa, CAP = 325
Recovered after 3 years: TE = 6.3 kPa, CAP = 278
IT M FL (USS)
Healthy (USS)
38
42
x 27 x Normal LFTs (ALT = 39), Chol = 2.9, TG = 0.98
Recovered after 4 years: TE = 5.8 kPa, CAP = 243
II M FL (USS)
Healthy (USS)
14
19
x 21 x Normal LFTs (ALT = 15), normal lipids
Recovered after 5 years: TE = 6.9 kPa, CAP = 216
II F Healthy (USS) 17 x 20 x Normal LFTs (ALT = 15), normal lipids; TE = 6.4 kPa, CAP = 216
II F Healthy (USS) 20 x <30 x Normal LFTs (ALT = 9), normal lipids

ALT, alanine transaminase (U/L); AP, alkaline phosphatase (U/L); ApoB, apolipoprotein B (g/L) (research laboratory data); CAP, controlled attenuation parameter (dB/m); Chol, cholesterol (mmol/L); FL, fatty liver; HbA1c, haemoglobin A1c; LFT, liver function test; NASH, non-alcoholic steatohepatitis; TE, transient elastography; TG, triglycerides (mmol/L); USS, abdominal ultrasonographic steatosis score.

Deduced from pedigree.